Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Therapy    entities : Thermo fisher scientific inc    save search

Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows
Published: 2024-01-17 (Crawled : 15:30) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.11% H: 0.0% C: 0.0%

first solution software cell therapy
Global Glioma Treatment Market Research Report 2023: Breakthrough Oncolytic Virus Therapy Offers New Hope for Glioma Patients - Forecast to 2027 and 2032
Published: 2023-11-27 (Crawled : 23:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.5% H: 0.0% C: 0.0%
KPTI | $1.265 -8.33% -9.09% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 4.0% H: 1.93% C: -7.72%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 0.85% C: 0.44%

report hope treatment research global virus therapy market
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Boehringer Ingelheim to Select Patients with NSCLC for Targeted Therapy Treatment
Published: 2023-10-19 (Crawled : 13:30) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -2.02% H: 0.0% C: 0.0%

diagnostic treatment companion agreement therapy
Thermo Fisher Scientific Helps Accelerate Cell Therapy Manufacturing with a Next-Generation Platform of Gibco™ CTS™ Detachable Dynabeads™
Published: 2023-09-06 (Crawled : 22:00) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -2.61% H: 0.0% C: 0.0%

cell therapy platform
Global Viral & Non-Viral Vector Manufacturing Market 2023 to 2027: Growing Prominence of Gene and Cell Therapy Products Fuels the Sector
Published: 2023-07-03 (Crawled : 22:00) - prnewswire.com
LZAGY | $57.3 0.02% 33K twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist
CTLT | $55.8 -0.29% 0.0% 1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
DHR | $236.36 -1.27% 0.0% 4.2M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
LZAGF | $579.0 -19.1% 49 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

cell global growing therapy market
Global Cell & Gene Therapy Manufacturing Services Market Report 2023: Major Players Include Thermo Fisher Scientific, Merck, Charles River Laboratories International and Lonza
Published: 2023-06-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49 twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 1.36% C: 1.36%
NINOY | $9.86 -3.3% 4.6K twitter stocktwits trandingview |
Manufacturing
| | O: 4.31% H: 0.0% C: -1.7%
LZAGY | $57.3 0.02% 33K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 2.0% H: 0.0% C: -0.97%
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 0.04% C: -1.46%
BLUE | $0.9583 -0.52% -0.52% 6.5M twitter stocktwits trandingview |
Health Technology
| | O: 1.62% H: 7.03% C: 2.39%

services report international cell global therapy market
Global Cell and Gene Therapy Biomanufacturing Markets Report 2022-2023 & 2031: Burgeoning Opportunities with a Robust Clinical Pipeline and Integration of Automation
Published: 2023-04-19 (Crawled : 15:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49 twitter stocktwits trandingview |
Health Technology
| | O: 1.28% H: 0.01% C: -1.16%
LZAGY | $57.3 0.02% 33K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -1.78% H: 0.74% C: 0.67%
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 0.86% C: 0.72%
GE | $152.94 -1.75% 0.0% 6M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.11% H: 0.74% C: 0.46%
DHR | $236.36 -1.27% 0.0% 4.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.64% H: 0.44% C: 0.1%
BIO | News | $281.02 -3.38% -0.36% 370K twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 2.71% C: 2.09%
BDX | $233.15 0.41% 0.15% 890K twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 1.75% C: 1.68%
TECH | $62.25 -0.77% -0.77% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 1.39% C: 1.11%

integration report pipeline cell global therapy
Increasing Investments and Fundings in Cell and Gene Therapy Fuelling the Growth of Cell and Gene Therapy Biomanufacturing, Suggests BIS Research Study
Published: 2023-03-24 (Crawled : 16:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49 twitter stocktwits trandingview |
Health Technology
| | O: -1.95% H: 0.8% C: -0.28%
LZAGY | $57.3 0.02% 33K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.34% H: 0.0% C: -0.03%
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.2% H: 1.85% C: 1.78%
GE | $152.94 -1.75% 0.0% 6M twitter stocktwits trandingview |
Electronic Technology
| | O: -1.11% H: 1.97% C: 0.88%
DHR | $236.36 -1.27% 0.0% 4.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 1.32% C: 1.24%
BIO | News | $281.02 -3.38% -0.36% 370K twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 1.8% C: 1.77%
BDX | $233.15 0.41% 0.15% 890K twitter stocktwits trandingview |
Health Technology
| | O: 0.19% H: 1.66% C: 1.55%
TECH | $62.25 -0.77% -0.77% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.46% H: 1.79% C: 1.33%

investments cell research therapy growth study
Market Forecasts for Immuno-Oncology Diagnostics 2023: Sector Represents a Revolution in Cancer Therapy
Published: 2023-01-20 (Crawled : 22:00) - prnewswire.com
ABT | News | $105.27 -0.6% -0.15% 7.3M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ANPCY | $1.98 338.38% 930 twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist
BIO | News | $281.02 -3.38% -0.36% 370K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
TXG | $28.96 -0.69% -0.69% 3M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVTA | $0.019 0.0% 22M twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BDX | $233.15 0.41% 0.15% 890K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ANPCF | $0.148 641.22% 5K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
CSTL | $19.19 1.86% 1.82% 140K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ICLR | $291.74 -0.1% -0.1% 500K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BIOC | $0.4349 -10.32% 750K twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist
NH | $1.35 -46.64% -1.48% 0 twitter stocktwits trandingview |
Technology Services
| Email alert Add to watchlist
MLAB | $100.05 -1.08% -1.09% 31K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

diagnostics therapy cancer market
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: 1.12% H: 0.0% C: -1.68%
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: -2.5% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 twitter stocktwits trandingview |
Health Technology
| | O: -1.16% H: 1.62% C: -0.54%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.25% C: -2.96%
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 0.97% C: -1.87%
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.84% C: -0.01%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 0.93% H: 0.01% C: -1.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 0.2% C: -1.1%
GSK | $39.27 -0.83% 0.01% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.03% H: 0.17% C: -1.01%
LLY | $745.95 -0.64% -0.1% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 0.75% C: -1.21%
ABT | News | $105.27 -0.6% -0.15% 7.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 0.33% C: -1.5%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.0% C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 0.46% C: -2.45%
AZN | $68.36 -0.25% -0.25% 4M twitter stocktwits trandingview |
Health Technology
| | O: 1.36% H: 0.33% C: -1.13%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.41% C: -1.87%

therapy growth
FDA Grants De Novo Classification to HLA Typing Test for Use as a Companion Diagnostic with a T Cell Receptor Therapy for Metastatic or Unresectable Uveal Melanoma
Published: 2022-12-07 (Crawled : 14:00) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.58% H: 0.0% C: 0.0%

fda melanoma test diagnostic grants therapy
Thermo Fisher Scientific Introduces All-in-One AAV Production System for Scalable Gene Therapy Workflows and Commercial Applications
Published: 2022-11-16 (Crawled : 14:00) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.71% H: 0.0% C: 0.0%

system commercial therapy
Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers
Published: 2022-09-27 (Crawled : 23:00) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 0.0% C: 0.0%

fda thyroid test diagnostic approval therapy
Stem Cell Therapy Global Market Report 2022: Rising Research and Development Spending, and Increasing Healthcare Expenditure Present Future Opportunities
Published: 2022-08-10 (Crawled : 16:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.61% C: 0.54%

research global report therapy market
Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
Published: 2022-06-06 (Crawled : 13:20) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.0% C: 0.0%

research solutions vaccine therapy
Thermo Fisher Scientific Introduces New Cell and Gene Therapy Integrated Commercial Packaging and Distribution Services
Published: 2022-02-15 (Crawled : 16:00) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.12% H: 0.66% C: -1.9%

gene therapy distribution cel services therapy commercialization
Worldwide Pharmaceutical Contract Development & Manufacturing Industry to 2026 - Growing Need for Cell and Gene Therapies Presents Opportunities
Published: 2021-12-14 (Crawled : 11:00) - prnewswire.com
LZAGF | $579.0 -19.1% 49 twitter stocktwits trandingview |
Health Technology
| | O: -2.62% H: 0.0% C: 0.0%
LZAGY | $57.3 0.02% 33K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -1.64% H: 0.19% C: -0.71%
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.0% C: 0.0%
DHR | $236.36 -1.27% 0.0% 4.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.0% C: 0.0%
CTLT | $55.8 -0.29% 0.0% 1M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.44% C: -0.68%

contract cel gene therapies growing gene therapy therapy
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 2.01% C: 0.82%
TAK | News | $13.16 0.08% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 2.03% H: 3.33% C: 0.07%
RGNX | $16.08 -5.58% -5.91% 560K twitter stocktwits trandingview |
Health Technology
| | O: 0.91% H: 2.93% C: 2.79%
BIIB | $190.55 -0.84% -0.84% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.19% H: 2.32% C: 1.7%

disease fda gene therapies therapy gene therapy rare
Outlook on the Regenerative Medicine Global Market to 2026 - Focus on Stem Cell Therapy, Biomaterial and Tissue Engineering Among Others
Published: 2021-10-18 (Crawled : 22:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.51% H: 1.02% C: 0.19%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 1.0% H: 0.23% C: -0.01%
MDT | $79.19 0.14% 0.0% 6.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.87% C: 0.4%
BDX | $233.15 0.41% 0.15% 890K twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 1.44% C: 1.35%
BAX | $39.65 0.33% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 1.64% C: 1.58%
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.29% C: -0.28%
IART | News | $31.63 -0.97% -0.98% 510K twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 1.84% C: 0.9%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.67% H: 1.18% C: 1.12%

stem cell therapy
New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies
Published: 2021-10-05 (Crawled : 15:00) - biospace.com/
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 1.91% C: 0.15%

gene therapies expansion therapy gene therapy
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.